Visus Therapeutics
Visus Therapeutics is a clinical-stage company developing innovative medicines to improve the vision for people around the world.
Last updated on
About Visus Therapeutics
Founded
2019Employees
11-50Funding / Mkt. Cap
$56MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
SeattleState
WashingtonCountry
United StatesVisus Therapeutics
Find your buyer within Visus Therapeutics
Tech Stack (44)
